https://www.reachrx.ai/hub/tag/warning/Univariate%20analyses%20only%20%E2%80%94%20no%20multivariate%20model%20was%20reported%2C%20so%20independent%20predictor%20weights%20cannot%20be%20confirmed.2026-03-25 https://www.reachrx.ai/hub/tag/warning/Universities%20were%20convenience%20sites%3B%20results%20are%20not%20nationally%20representative.2025-11-26 https://www.reachrx.ai/hub/tag/warning/Up%20to%20four%20timepoints%20per%20participant%20were%20used%2C%20but%20not%20all%20participants%20completed%20all%20timepoints%2C%20which%20may%20introduce%20bias%20in%20trajectory%20groupings.2026-04-20 https://www.reachrx.ai/hub/tag/warning/Upadacitinib%20is%20mentioned%20in%20the%20discussion%20as%20a%20GC-sparing%20agent%20but%20was%20not%20part%20of%20the%20exposure%20analysis%3B%20its%20real-world%20uptake%20is%20not%20described%20in%20this%20dataset.2026-07-07 https://www.reachrx.ai/hub/tag/warning/UPF%20classification%20systems%20(e.g.%2C%20NOVA)%20vary%20across%20cited%20studies%2C%20which%20may%20affect%20consistency%20of%20the%20epidemiological%20associations%20described.2026-05-10 https://www.reachrx.ai/hub/tag/warning/UPF%20was%20not%20defined%20explicitly%20in%20the%20abstract%3B%20the%20NOVA%20classification%20is%20implied%20but%20not%20confirmed%20in%20the%20provided%20text.2026-05-05 https://www.reachrx.ai/hub/tag/warning/Upper%20confidence%20interval%20for%20median%20OS%20in%20Arms%20A%20and%20C%20was%20'not%20estimable'%20at%20data%20cutoff%2C%20indicating%20survival%20data%20may%20still%20be%20maturing%20despite%20the%20futility%20call.2026-07-14 https://www.reachrx.ai/hub/tag/warning/Urban-only%20site%20selection%20limits%20generalisability%3B%20authors%20explicitly%20advise%20against%20national%20extrapolation.2026-04-26 https://www.reachrx.ai/hub/tag/warning/Urinary%20aluminum%20increase%20is%20a%20temporal%20observation%20in%20a%20single%20patient%20%E2%80%94%20it%20cannot%20establish%20mobilization%2C%20reduced%20tissue%20burden%2C%20or%20any%20clinical%20benefit.2026-06-23 https://www.reachrx.ai/hub/tag/warning/Urine%20pH%20was%20collected%20but%20no%20results%20are%20shown%20in%20the%20provided%20text.2025-12-08 https://www.reachrx.ai/hub/tag/warning/UroActive%20has%20not%20received%20FDA%20or%20EU%20marketing%20authorization%3B%20the%20device%20is%20not%20commercially%20available%20as%20of%20the%20publication%20date.2026-01-21 https://www.reachrx.ai/hub/tag/warning/Use%20of%20hypothetical%20pain%20graphs%20as%20a%20discussion%20prompt%20may%20have%20anchored%20or%20biased%20participant%20responses%20toward%20pain-centric%20frameworks.2026-05-18 https://www.reachrx.ai/hub/tag/warning/Use%20of%20the%20California%20Healthy%20Places%20Index%20may%20limit%20applicability%20outside%20California%3B%20generalizability%20is%20not%20specified.2025-11-20 https://www.reachrx.ai/hub/tag/warning/User%20profession%20data%20(medical%20doctors%2C%20nurse%20practitioners)%20was%20only%20reported%20for%20the%20registration-based%20platform%3B%20open-access%20user%20demographics%20are%20largely%20unknown.2026-05-07 https://www.reachrx.ai/hub/tag/warning/Users%20should%20retrieve%20the%20full%20text%20to%20obtain%20specific%20accuracy%20metrics%2C%20sample%20size%2C%20and%20clinical%20conclusions.2026-08-07 https://www.reachrx.ai/hub/tag/warning/Ustekinumab%20is%20not%20FDA-approved%20specifically%20for%20UC%20in%20the%20same%20manner%20as%20for%20Crohn's%20disease%3B%20its%20use%20in%20this%20context%20may%20reflect%20off-label%20or%20region-specific%20prescribing%20practices.2026-08-07 https://www.reachrx.ai/hub/tag/warning/Usual%20care%20content%20in%20the%20control%20group%20is%20not%20described%20in%20the%20abstract%2C%20making%20it%20difficult%20to%20judge%20the%20active%20ingredient%20of%20the%20intervention.2026-05-20 https://www.reachrx.ai/hub/tag/warning/Uterine%20volume%20was%20calculated%20using%20the%202D%20ellipsoid%20formula%3B%20measurement%20variability%20and%20lack%20of%203D%20volumetry%20may%20introduce%20imprecision%20in%20the%20volume-outcome%20analyses.2026-05-25 https://www.reachrx.ai/hub/tag/warning/Utility%20is%20limited%20to%20seropositive%20patients%20(49%25%20in%20this%20cohort).2025-09-10 https://www.reachrx.ai/hub/tag/warning/Vaccinated%20counts%20included%20differ%20from%20reported%20coverage%20figures%20(e.g.%2C%20Tdap%2053%2C448%20included%20vs%2070%2C119%20coverage)%2C%20suggesting%20different%20denominators.2026-01-08 https://www.reachrx.ai/hub/tag/warning/Vaccination%20analyses%20apply%20to%20ages%205%20to%20%3C18%20years%20and%20to%20BNT162b2%20only%2C%20which%20may%20limit%20generalizability%20to%20other%20vaccines%20or%20age%20bands.2025-11-07 https://www.reachrx.ai/hub/tag/warning/Vaccination%20effects%20are%20described%20as%20emerging%3B%20strength%20and%20magnitude%20are%20not%20specified.2026-01-07 https://www.reachrx.ai/hub/tag/warning/Vaccination%20status%20(influenza%20and%20pneumococcal)%20was%20not%20available%20as%20a%20covariate%2C%20which%20is%20a%20notable%20unmeasured%20confounder%20for%20pneumonia%20outcomes.2026-04-21 https://www.reachrx.ai/hub/tag/warning/Vaccination%20status%20was%20inferred%20from%20absence%20of%20EHR%20records%2C%20which%20may%20misclassify%20some%20vaccinated%20individuals%20as%20unvaccinated.2026-04-17 https://www.reachrx.ai/hub/tag/warning/Vaccination%20status%2C%20COVID-19%20variant%20at%20time%20of%20infection%2C%20and%20time%20elapsed%20since%20acute%20illness%20are%20not%20reported%2C%20which%20may%20affect%20generalizability.2026-07-24 https://www.reachrx.ai/hub/tag/warning/Vaccine-associated%20myocarditis%20cases%20are%20mentioned%20as%20a%20study%20focus%20but%20are%20not%20broken%20out%20numerically%20in%20the%20abstract%2C%20limiting%20interpretation%20of%20vaccine%20vs.%20infection%20contribution.2026-05-17 https://www.reachrx.ai/hub/tag/warning/Vaccine%20brand%20is%20not%20specified%20in%20the%20abstract%3B%20only%20a%209-valent%20alphapapillomavirus%20vaccine%20is%20named.2025-03-06 https://www.reachrx.ai/hub/tag/warning/Vaccine%20brand%20name%20is%20not%20specified%20beyond%20'quadrivalent'%3B%20no%20brand%20tag%20applied.2026-06-03 https://www.reachrx.ai/hub/tag/warning/Vaccine%20effectiveness%20against%20specific%20circulating%20strains%20per%20season%20was%20not%20reported%2C%20which%20may%20affect%20interpretation%20of%20symptom%20differences%20across%20seasons.2026-08-13 https://www.reachrx.ai/hub/tag/warning/Vaccine%20effectiveness%20estimates%20are%20against%20all-serotype%20outcomes%2C%20not%20PCV20-specific%20serotypes%2C%20which%20may%20underestimate%20true%20serotype-specific%20effectiveness.2026-04-30 https://www.reachrx.ai/hub/tag/warning/Vaccine%20effectiveness%20used%20a%20nonrandomized%20survey%20comparator.2025-12-03 https://www.reachrx.ai/hub/tag/warning/Vaccine%20type%20(e.g.%2C%20bivalent%2C%20quadrivalent%2C%20nonavalent)%20is%20mentioned%20as%20an%20examined%20variable%20but%20no%20type-specific%20results%20are%20summarized%20in%20the%20available%20text.2026-05-10 https://www.reachrx.ai/hub/tag/warning/Vaccine%20type%E2%80%93specific%20subgroup%20analyses%20(influenza%2C%20COVID-19%2C%20tetanus)%20were%20individually%20non-significant%3B%20the%20overall%2090-day%20null%20result%20should%20be%20weighted%20accordingly.2026-06-22 https://www.reachrx.ai/hub/tag/warning/Vaccine%20uptake%20was%20only%209.6%25%20(2-dose)%2C%20which%20is%20much%20lower%20than%20anticipated%3B%20this%20limits%20the%20precision%20of%20VE%20estimates%20and%20may%20affect%20generalizability.2026-08-04 https://www.reachrx.ai/hub/tag/warning/Vaginal%20estrogen%20for%20rUTI%20prevention%20is%20off-label%20in%20all%20major%20jurisdictions%20reviewed%20(FDA%2C%20EMA%2C%20MHRA)%3B%20clinical%20use%20is%20guideline-supported%20but%20not%20regulatory-approved%20for%20this%20indication.2026-06-30 https://www.reachrx.ai/hub/tag/warning/Vaginal%20estrogen%20is%20not%20classified%20by%20brand%20or%20generic%20here%20as%20the%20study%20does%20not%20specify%20a%20single%20formulation%3B%20multiple%20products%20exist%20(estradiol%2C%20estriol%2C%20conjugated%20estrogens).2026-06-10 https://www.reachrx.ai/hub/tag/warning/Validation%20biomarker%20score%20excluded%20MMP-2%20compared%20with%20development%20cohorts.2025-09-16 https://www.reachrx.ai/hub/tag/warning/Validation%20cohort%20estimated%20sodium%20by%20dietary%20recall%20rather%20than%20urine%20biomarkers.2024-06-05 https://www.reachrx.ai/hub/tag/warning/Validation%20criteria%20rely%20entirely%20on%20anonymous%20self-report%2C%20which%20underestimates%20true%20prevalence%20and%20may%20inflate%20apparent%20VT%20sensitivity.2026-08-08 https://www.reachrx.ai/hub/tag/warning/Validation%20is%20based%20on%20clinical%20vignettes%3B%20prospective%20patient-level%20validation%20is%20pending.2025-11-23 https://www.reachrx.ai/hub/tag/warning/Validation%20was%20internal%20(train-test%20split)%20only%3B%20no%20external%20cohort%20was%20used%2C%20limiting%20generalizability.2026-05-24 https://www.reachrx.ai/hub/tag/warning/Validation%20was%20performed%20using%20Monte%20Carlo%20cross-validation%20on%20the%20same%20cohort%2C%20not%20a%20fully%20independent%20prospective%20test%20set%3B%20the%20external%20cohort%20was%20tissue-based%2C%20not%20plasma-based.2026-07-24 https://www.reachrx.ai/hub/tag/warning/Validity%20and%20reliability%20are%20reported%20qualitatively%20in%20the%20abstract%20without%20numerical%20metrics.2025-11-23 https://www.reachrx.ai/hub/tag/warning/Vamikibart%20does%20not%20yet%20have%20a%20brand%20name%3B%20it%20is%20referred%20to%20by%20INN%20only.2026-04-09 https://www.reachrx.ai/hub/tag/warning/Vancomycin%20tagged%20as%20likely%20agent%20for%20MRSA%20management%20but%20is%20not%20explicitly%20named%20in%20the%20source%20text.2026-05-26 https://www.reachrx.ai/hub/tag/warning/Variance%20explained%20(%E2%80%9Cup%20to%2053%25%E2%80%9D)%20is%20reported%20without%20domain-by-domain%20breakdown%20in%20the%20abstract.2026-01-14 https://www.reachrx.ai/hub/tag/warning/Variant%20classification%20is%20period-based%20(Omicron-dominated%20era%20vs.%20earlier)%2C%20not%20confirmed%20by%20individual%20genomic%20sequencing%2C%20which%20may%20introduce%20misclassification.2026-05-27 https://www.reachrx.ai/hub/tag/warning/Variant%20classification%20was%20based%20on%20estimated%20date%20of%20symptom%20onset%20and%20dominant%20UK%20circulating%20strain%2C%20not%20confirmed%20viral%20sequencing%20%E2%80%94%20variant-specific%20cognitive%20findings%20are%20exploratory%20only.2026-07-22 https://www.reachrx.ai/hub/tag/warning/Variant%20pathogenicity%20was%20supported%20by%20in-silico%20modeling%20only%20%E2%80%94%20no%20functional%2Fin-vitro%20validation%20was%20performed.2026-05-08 https://www.reachrx.ai/hub/tag/warning/Variants%20of%20uncertain%20significance%20are%20included%20alongside%20pathogenic%2Flikely%20pathogenic%20variants%2C%20which%20may%20heterogenize%20the%20cohort%20and%20limit%20interpretability%20of%20outcomes%20attributed%20to%20ABCA3%20pathogenicity.2026-06-15 https://www.reachrx.ai/hub/tag/warning/VAS%20fatigue%20comparison%20between%20MF%2FSS%20and%20psoriasis%20did%20not%20reach%20significance%20(p%3D0.49)%20despite%20a%20numerically%20higher%20median%20in%20MF%2FSS%2C%20which%20may%20reflect%20insufficient%20power.2026-07-15 https://www.reachrx.ai/hub/tag/warning/VAS%20scale%20direction%20and%20minimal%20clinically%20important%20difference%20are%20not%20described%20here%2C%20so%20the%20clinical%20meaning%20of%20negative%20differences%20is%20uncertain.2025-10-22 https://www.reachrx.ai/hub/tag/warning/VCI%20is%20a%20novel%20metric%20not%20yet%20integrated%20into%20standard%20reporting%20software%3B%20clinical%20implementation%20details%20are%20not%20described%20in%20the%20abstract.2026-06-01 https://www.reachrx.ai/hub/tag/warning/VCTE%20was%20used%20for%20liver%20assessment%3B%20results%20may%20not%20perfectly%20align%20with%20biopsy-based%20staging.2026-07-09 https://www.reachrx.ai/hub/tag/warning/VDAC1%20is%20primarily%20known%20as%20a%20mitochondrial%20outer%20membrane%20channel%3B%20its%20role%20as%20an%20R-loop%20regulator%20is%20a%20novel%20and%20not%20yet%20widely%20validated%20claim.2026-05-26 https://www.reachrx.ai/hub/tag/warning/VE%20estimates%20are%20specific%20to%20outpatient%20mild-to-moderate%20illness%20and%20should%20not%20be%20generalized%20to%20inpatient%20or%20severe%20disease%20outcomes.2026-07-14 https://www.reachrx.ai/hub/tag/warning/Vedolizumab%20brand%20tag%20added%20for%20clarity%2C%20though%20'Entyvio'%20is%20the%20marketed%20brand%20name%3B%20'Vedolizumab'%20used%20here%20as%20noted%20in%20the%20paper.2026-04-10 https://www.reachrx.ai/hub/tag/warning/Vedolizumab%20showing%20higher%20serious%20infection%20risk%20than%20anti-TNF%20(aHR%201.07%20vs.%20aminosalicylates%201.38%20vs.%201.29)%20is%20counterintuitive%20given%20its%20gut-selective%20mechanism%3B%20residual%20confounding%20or%20channeling%20bias%20(more%20complex%20patients%20receiving%20vedolizumab)%20may%20explain%20this%20finding.2026-04-27 https://www.reachrx.ai/hub/tag/warning/Veligrotug%20does%20not%20appear%20to%20have%20regulatory%20approval%20as%20of%20the%20knowledge%20cutoff%3B%20'promising%20new%20treatment%20option'%20language%20in%20the%20abstract%20reflects%20investigational%20status.2026-06-01 https://www.reachrx.ai/hub/tag/warning/Venezuela's%20'doublet'%20earthquake%20refers%20to%20a%20paired%20seismic%20event%3B%20the%20specific%20events%20referenced%20could%20not%20be%20confirmed%20from%20the%20available%20metadata%20alone.2026-07-04 https://www.reachrx.ai/hub/tag/warning/Verification%20bias%20is%20a%20significant%20concern%3A%20CE-MRI%20(reference%20standard)%20was%20only%20performed%20in%20screen-positive%20patients%2C%20which%20may%20artificially%20inflate%20sensitivity%20and%20specificity%20estimates%20for%20both%20modalities.2026-05-11 https://www.reachrx.ai/hub/tag/warning/Verteporfin%20(branded%20as%20Visudyne)%20is%20currently%20approved%20for%20photodynamic%20therapy%20in%20macular%20degeneration%2C%20not%20for%20preeclampsia%3B%20its%20use%20here%20is%20investigational%2Fex%20vivo%20only.2026-04-09 https://www.reachrx.ai/hub/tag/warning/VERVE-102%20has%20no%20approved%20nonproprietary%20INN%3B%20the%20generic%20tag%20reflects%20a%20descriptive%20label%20based%20on%20available%20information.2026-05-25 https://www.reachrx.ai/hub/tag/warning/Very%20few%20RSV%20hospitalization%20events%3B%20estimates%20have%20wide%20confidence%20intervals.2025-09-01 https://www.reachrx.ai/hub/tag/warning/Very%20high%20heterogeneity%20(I%C2%B2%3D98.2%25)%20means%20the%20pooled%2054%25%20mortality%20estimate%20should%20be%20interpreted%20cautiously%20%E2%80%94%20it%20reflects%20wide%20variation%20across%20outbreaks%20and%20settings%20rather%20than%20a%20single%20precise%20figure.2026-05-20 https://www.reachrx.ai/hub/tag/warning/Very%20high%20heterogeneity%20limits%20precision%20of%20pooled%20thresholds.2025-11-26 https://www.reachrx.ai/hub/tag/warning/Very%20limited%20clinical%20data%20are%20available%20from%20the%20abstract%20alone%3B%20histopathology%2C%20dermoscopy%20findings%2C%20and%20treatment%20are%20not%20described.2026-06-24 https://www.reachrx.ai/hub/tag/warning/Very%20low%20circulation%20of%20influenza%20B%20in%20the%20study%20season%20limits%20conclusions%20about%20B-strain%20efficacy%20and%20immunogenicity.2025-11-19 https://www.reachrx.ai/hub/tag/warning/Very%20low%20completion%20rate%20(614%2F256%2C053%20~0.24%25)%20may%20reflect%20significant%20self-selection%20bias%2C%20which%20could%20inflate%20apparent%20screening%20performance.2026-06-04 https://www.reachrx.ai/hub/tag/warning/Very%20low%20survey%20response%20rate%20(14%25)%20is%20a%20major%20limitation%20and%20likely%20introduces%20selection%20bias%20toward%20more%20engaged%20or%20specialist-leaning%20rheumatologists.%20Results%20may%20not%20reflect%20true%20practice%20patterns%20across%20the%20broader%20community.2026-06-10 https://www.reachrx.ai/hub/tag/warning/Very%20small%20case%20series%20(n%3D2)%3B%20findings%20and%20management%20recommendations%20should%20be%20interpreted%20with%20caution%20and%20cannot%20be%20generalized%20without%20larger%20studies.2026-06-26 https://www.reachrx.ai/hub/tag/warning/Very%20small%20cohort%20(n%3D23)%20with%20only%207%20AOA-positive%20patients%3B%20all%20within-group%20correlations%20should%20be%20interpreted%20with%20caution%20due%20to%20severely%20limited%20statistical%20power.2026-05-19 https://www.reachrx.ai/hub/tag/warning/Very%20small%20HIV-positive%20group%20(n%3D21)%20means%20findings%20should%20be%20interpreted%20cautiously%3B%20this%20is%20a%20pilot%20study%20not%20powered%20for%20definitive%20conclusions.2026-05-25 https://www.reachrx.ai/hub/tag/warning/Very%20small%20lymph%20node%20cohort%20(n%3D13)%20limits%20statistical%20power%20and%20generalizability%3B%20GC%20persistence%20seen%20in%20only%205%20of%2013%20participants.2026-06-15 https://www.reachrx.ai/hub/tag/warning/Very%20small%20number%20of%20torsion%20events%20(n%3D6)%20and%20single-center%20retrospective%20design%20limit%20certainty.2026-01-09 https://www.reachrx.ai/hub/tag/warning/Very%20small%20per-group%20sample%20size%20(n%3D12)%20makes%20this%20an%20exploratory%20pilot%3B%20authors%20acknowledge%20it%20is%20underpowered%20to%20detect%20smaller%20between-group%20differences.2026-06-08 https://www.reachrx.ai/hub/tag/warning/Very%20small%20sample%20(3%20exposed%20vs%204%20unexposed)%3B%20generalizability%20and%20causality%20are%20limited.2026-01-13 https://www.reachrx.ai/hub/tag/warning/Very%20small%20sample%20(n%3D10)%20and%20short%20duration%20(~2%20weeks)%3B%20generalizability%20is%20limited.2025-02-05 https://www.reachrx.ai/hub/tag/warning/Very%20small%20sample%20(n%3D11)%3B%20findings%20should%20be%20interpreted%20with%20caution%20and%20not%20generalized%20broadly.2026-06-30 https://www.reachrx.ai/hub/tag/warning/Very%20small%20sample%20(n%3D25)%3B%20effect%20sizes%20and%20confidence%20intervals%20should%20be%20interpreted%20cautiously%20%E2%80%94%20results%20are%20explicitly%20described%20as%20preliminary.2026-06-15 https://www.reachrx.ai/hub/tag/warning/Very%20small%20sample%20(n%3D63)%20means%20confidence%20intervals%20are%20wide%3B%20RR%20estimates%20should%20be%20interpreted%20cautiously.2026-06-03 https://www.reachrx.ai/hub/tag/warning/Very%20small%20sample%20size%20(n%3D12)%3B%20results%20should%20be%20interpreted%20as%20hypothesis-generating%20only.2026-07-01 https://www.reachrx.ai/hub/tag/warning/Very%20small%20sample%20size%20(n%3D12%2C%20all%20male)%20limits%20statistical%20power%20and%20generalizability%3B%20findings%20should%20be%20interpreted%20with%20caution.2026-03-14 https://www.reachrx.ai/hub/tag/warning/Very%20small%20sample%20size%20(n%3D13)%3B%20findings%20should%20be%20interpreted%20as%20preliminary%20and%20hypothesis-generating%20only.2026-06-03 https://www.reachrx.ai/hub/tag/warning/Very%20small%20sample%20size%20(n%3D17%20total%3B%20n%3D10%20COPD%2C%20n%3D7%20controls)%20%E2%80%94%20findings%20should%20be%20considered%20exploratory%20and%20hypothesis-generating%20only.2026-05-18 https://www.reachrx.ai/hub/tag/warning/Very%20small%20sample%20size%20(n%3D18)%20and%20single-center%20setting%20constrain%20inference.2026-01-11 https://www.reachrx.ai/hub/tag/warning/Very%20small%20sample%20size%20(n%3D23)%20makes%20this%20a%20feasibility%20study%3B%20results%20should%20be%20interpreted%20with%20caution%20pending%20larger%20confirmatory%20trials.2026-05-21 https://www.reachrx.ai/hub/tag/warning/Very%20small%20sample%20size%20(n%3D23)%20produces%20highly%20imprecise%20odds%20ratios%20(e.g.%2C%2095%25%20CI%201.41%E2%80%93192.00)%3B%20findings%20should%20be%20considered%20hypothesis-generating%20only.2026-06-08 https://www.reachrx.ai/hub/tag/warning/Very%20small%20sample%20size%20(n%3D30)%20may%20be%20underpowered%20to%20detect%20differences%20in%20secondary%20outcomes%20or%20rare%20harms%20like%20re-tear.%20Re-tear%20rates%20were%20not%20explicitly%20reported%2C%20making%20it%20difficult%20to%20fully%20assess%20safety.%20The%20study%20is%20restricted%20to%20medium-sized%20full-thickness%20tears%3B%20generalizability%20to%20other%20tear%20sizes%20is%20uncertain.%20The%20paper's%20DOI%20and%20publication%20date%20are%20in%202026%2C%20which%20is%20future%20relative%20to%20most%20training%20data%20%E2%80%94%20content%20is%20taken%20at%20face%20value%20as%20provided.2026-07-15 https://www.reachrx.ai/hub/tag/warning/Very%20small%20sample%20size%20(n%3D32%20across%203%20arms)%20means%20the%20trial%20is%20likely%20underpowered%20to%20detect%20clinically%20meaningful%20weight%20differences%3B%20results%20should%20be%20interpreted%20cautiously.2026-08-17 https://www.reachrx.ai/hub/tag/warning/Very%20small%20sample%20size%20(n%3D37)%20substantially%20limits%20statistical%20power%3B%20null%20correlations%20should%20be%20interpreted%20cautiously%20as%20absence%20of%20evidence%20rather%20than%20evidence%20of%20absence.2026-07-06 https://www.reachrx.ai/hub/tag/warning/Very%20small%20sample%20size%20(n%3D38)%20makes%20subgroup%20comparisons%20(UC%20vs.%20CD)%20underpowered%3B%20results%20should%20be%20interpreted%20with%20caution.2026-07-26 https://www.reachrx.ai/hub/tag/warning/Very%20small%20sample%20size%20(n%3D46)%20despite%20243%20patients%20approached%3B%20high%20exclusion%20rate%20may%20limit%20generalizability.2026-05-20 https://www.reachrx.ai/hub/tag/warning/Very%20small%20sample%20size%20(n%3D60%20total%3B%2030%20per%20arm)%20%E2%80%94%20effect%20sizes%20are%20large%20but%20confidence%20intervals%20are%20wide%3B%20results%20should%20be%20interpreted%20with%20caution%20pending%20larger%20replication.2026-05-26 https://www.reachrx.ai/hub/tag/warning/Very%20small%20sample%20size%20(n%3D9%20HSAM)%20substantially%20limits%20statistical%20power%20and%20the%20reliability%20of%20effect%20size%20estimates.2026-05-08 https://www.reachrx.ai/hub/tag/warning/Very%20small%20single%20focus%20group%20(n%3D12)%3B%20findings%20may%20not%20generalise%20beyond%20this%20pilot's%20geographic%20or%20organisational%20context.2026-04-27 https://www.reachrx.ai/hub/tag/warning/Very%20small%20subgroup%20for%20drug-resistant%20CMV%20(n%3D7)%20%E2%80%94%20odds%20ratio%20estimates%20for%20resistance%20should%20be%20interpreted%20with%20caution.2026-04-29 https://www.reachrx.ai/hub/tag/warning/Very%20small%2C%20uncontrolled%20sample%20(n%3D11)%20limits%20inference%3B%20only%208%20completed%20the%20full%20protocol.2026-01-01 https://www.reachrx.ai/hub/tag/warning/Video%20analyzability%20was%20only%2043%25%2C%20and%20reasons%20for%20non-analyzable%20videos%20are%20not%20detailed%2C%20which%20limits%20confidence%20in%20the%20performance%20score%20estimates.2026-05-09 https://www.reachrx.ai/hub/tag/warning/Video%20laryngoscopy%20intubations%20were%20excluded%2C%20so%20findings%20do%20not%20apply%20to%20video-assisted%20techniques%2C%20which%20are%20increasingly%20common%20in%20paediatric%20emergency%20airway%20management.2026-07-12 https://www.reachrx.ai/hub/tag/warning/VILPA%20and%20MV-ILPA%20are%20research-defined%20constructs%20not%20yet%20standardized%20in%20clinical%20guidelines%3B%20thresholds%20may%20not%20directly%20map%20to%20existing%20physical%20activity%20recommendations.2026-04-28 https://www.reachrx.ai/hub/tag/warning/Viral%20strain%20subtyping%20was%20not%20performed%20for%20most%20cases%2C%20so%20variant-specific%20effects%20cannot%20be%20assessed.2026-06-16 https://www.reachrx.ai/hub/tag/warning/VisionFM%20and%20RETFound%20are%20model%20names%2C%20not%20drug%20generics%20%E2%80%94%20tagged%20under%20'generic'%20as%20a%20closest%20available%20category%3B%20no%20brand%2Fdrug%20modality%20applies%20here.2026-05-05 https://www.reachrx.ai/hub/tag/warning/Visual%20CT%20assessment%20for%20emphysema%20extent%20may%20introduce%20inter-reader%20variability%3B%20quantitative%20CT%20thresholds%20were%20not%20used.2026-07-08 https://www.reachrx.ai/hub/tag/warning/Vitamin%20D%20deficiency%20was%20an%20exploratory%20outcome.2025-09-10 https://www.reachrx.ai/hub/tag/warning/Vitamin%20D%20effect%20modification%20is%20observational%20only%3B%20authors%20explicitly%20caution%20against%20inferring%20a%20supplementation%20benefit.2026-08-04 https://www.reachrx.ai/hub/tag/warning/Vitamin%20D%20is%20listed%20as%20a%20component%20but%20its%20independent%20contribution%20to%20outcomes%20is%20not%20assessed%20separately%20from%20the%20synbiotic%20combination.2026-08-12 https://www.reachrx.ai/hub/tag/warning/Vitrectomy%20vs.%20observation%20comparison%20is%20observational%20and%20subject%20to%20confounding%20by%20indication%20%E2%80%94%20the%20authors%20acknowledge%20this%20limitation.2026-05-23 https://www.reachrx.ai/hub/tag/warning/VOC%20determination%20was%20unavailable%20for%208.5%25%20of%20positive%20cases%20due%20to%20low%20viral%20load%2C%20introducing%20potential%20misclassification%20in%20variant-specific%20analyses.2026-07-31 https://www.reachrx.ai/hub/tag/warning/Vonoprazan%2C%20the%20most%20widely%20used%20P-CAB%20globally%2C%20was%20not%20available%20in%20South%20Korea%20during%20the%20study%20period%20and%20was%20excluded%3B%20results%20may%20not%20generalize%20to%20vonoprazan%20users.2026-04-01 https://www.reachrx.ai/hub/tag/warning/VTE%20events%20were%20investigator-reported%2C%20not%20centrally%20adjudicated%2C%20which%20may%20introduce%20misclassification%20bias.2026-05-27 https://www.reachrx.ai/hub/tag/warning/VTI%20findings%20represent%20relative%20hemodynamics%2C%20not%20absolute%20flow%2C%20because%20vessel%20diameters%20were%20not%20measured.2025-11-25 https://www.reachrx.ai/hub/tag/warning/VUR%20status%20was%20unknown%20for%20a%20substantial%20portion%20of%20patients%2C%20as%20VCUG%20was%20only%20performed%20selectively%3B%20this%20adds%20uncertainty%20to%20the%20reflux-free%20subgroup%20analysis.2026-01-30 https://www.reachrx.ai/hub/tag/warning/W010%20and%20W014%20are%20investigational%20antibody%20identifiers%20from%20this%20study%2C%20not%20approved%20or%20named%20therapeutics%3B%20brand%2FRxNorm%20tags%20are%20not%20applicable.2026-06-22 https://www.reachrx.ai/hub/tag/warning/Waist-to-height%20ratio%20threshold%20of%20~0.6%20for%20elevated%20LRE%20risk%20is%20described%20as%20exploratory%20and%20not%20yet%20validated%20in%20independent%20cohorts.2026-07-27 https://www.reachrx.ai/hub/tag/warning/Waist%20circumference%20unit%20appears%20inconsistent%20in%20the%20abstract%3B%20the%20reported%20MD%20is%20%E2%88%921.32%20without%20a%20reliable%20unit.2025-11-28 https://www.reachrx.ai/hub/tag/warning/Wait-list%20control%20rather%20than%20an%20active%20comparator.2023-07-19 https://www.reachrx.ai/hub/tag/warning/Wait%20time%20figures%20are%20GP%20estimates%2C%20not%20verified%20administrative%20data.2026-07-28 https://www.reachrx.ai/hub/tag/warning/Watch-and-wait%2Fnon-operative%20management%20outcomes%20were%20not%20reported%2C%20which%20is%20clinically%20relevant%20given%20the%20high%20pCR%20rate%20(26.4%25)%20in%20the%20doublet-LC%20TNT%20arm.2026-07-23 https://www.reachrx.ai/hub/tag/warning/Week-16%20interim%20results%20only%3B%20longer-term%20(through%20week%2052)%20outcomes%20are%20pending.2025-10-26 https://www.reachrx.ai/hub/tag/warning/Week%2024%20outcomes%20were%20reported%20as%20ad%20hoc%20analyses%20and%20should%20be%20interpreted%20cautiously.2024-11-27 https://www.reachrx.ai/hub/tag/warning/Week%2048%20results%20reflect%20secondary%20endpoints%3B%20the%20primary%20endpoint%20is%20not%20detailed%20here.2026-01-18 https://www.reachrx.ai/hub/tag/warning/Weekly%20adalimumab%20remains%20off-label%20for%20uveitis%20in%20this%20population%3B%20the%20study%20reflects%20real-world%20UK%20tertiary%20practice%20and%20may%20not%20generalise%20to%20other%20healthcare%20settings.2026-05-29 https://www.reachrx.ai/hub/tag/warning/Weight-loss%20results%20come%20from%20a%20subset%20(257%20GLP-1%20RA%3B%201%2C291%20MBS)%2C%20which%20may%20limit%20generalizability.2025-09-17 https://www.reachrx.ai/hub/tag/warning/Weight%20loss%20outcomes%20are%20not%20reported%20in%20the%20abstract%3B%20the%20primary%20endpoint%20was%20glycemic%20control%20only%E2%80%94body%20weight%20data%20would%20require%20review%20of%20the%20full%20publication.2026-06-07 https://www.reachrx.ai/hub/tag/warning/Weight%20regain%20after%20MBS%20could%20not%20be%20measured%3B%20it%20is%20unclear%20whether%20late%20IBD%20risk%20is%20driven%20by%20weight%20trajectory%2C%20microbiome%20changes%2C%20or%20both.2026-05-05 https://www.reachrx.ai/hub/tag/warning/Weight%20values%20(35.8%20kg%20and%2033.8%20kg)%20are%20extracted%20from%20a%20figure%20description%20and%20may%20be%20approximate.2026-06-08 https://www.reachrx.ai/hub/tag/warning/Weighted%20sample%20(224%20million%20children)%20represents%20US%20population%20extrapolation%20from%20263%2C168%20survey%20respondents%20%E2%80%94%20absolute%20counts%20should%20not%20be%20interpreted%20as%20individual-level%20data.2026-03-30 https://www.reachrx.ai/hub/tag/warning/Weinberg's%20differential%20rule%20used%20to%20estimate%20monozygotic%20twinning%20rate%20in%20absence%20of%20actual%20zygosity%20data%20%E2%80%94%20some%20misclassification%20is%20possible.2026-05-24 https://www.reachrx.ai/hub/tag/warning/Welsh%20data%20quality%20is%20materially%20compromised%20by%20an%20ongoing%20cancer%20informatics%20system%20transition%2C%20and%20several%20key%20indicators%20could%20not%20be%20reported%20for%20Wales.2026-05-15 https://www.reachrx.ai/hub/tag/warning/West%20African%20ancestry%20data%20was%20unavailable%20for%20a%20subset%20of%20participants%20(~18%25)%2C%20which%20may%20affect%20ancestry-stratified%20comparisons.2026-06-08 https://www.reachrx.ai/hub/tag/warning/Wheeze%20outcomes%20were%20defined%20by%20questionnaire%2C%20not%20objective%20lung%20function%20measures%3B%20'repeated%20childhood%20wheeze'%20may%20not%20align%20precisely%20with%20clinical%20definitions%20across%20studies.2026-05-16 https://www.reachrx.ai/hub/tag/warning/Whether%20bacterial%20and%20viral%20co-infections%20overlapped%20is%20unclear.2025-12-29 https://www.reachrx.ai/hub/tag/warning/Whether%20the%20work%20is%20preclinical%20or%20clinical%20is%20unclear%20from%20the%20information%20given.2026-01-16 https://www.reachrx.ai/hub/tag/warning/White%20matter%20integrity%20and%20ACEI%2FARB%20analyses%20are%20mentioned%20but%20specific%20results%20are%20not%20provided%20in%20the%20abstract.2026-01-07 https://www.reachrx.ai/hub/tag/warning/White%20patients%20were%20a%20minority%20within%20this%20Asia-Pacific%20cohort%3B%20findings%20of%20higher%20MC-A%20and%20MC-D%20rates%20in%20White%20patients%20should%20be%20interpreted%20cautiously%20given%20potential%20for%20small-subgroup%20effects.2026-04-06 https://www.reachrx.ai/hub/tag/warning/Whole-genome%20sequencing%20was%20conducted%20on%20only%2041%20of%2070%20isolates%3B%20clonal%20complex%20distribution%20may%20not%20fully%20represent%20the%20entire%20cohort.2026-06-11 https://www.reachrx.ai/hub/tag/warning/Whole%20genome%20sequencing%20was%20performed%20on%20only%2015%2F24%20CTX-M-negative%20isolates%2C%20so%20resistance%20mechanism%20characterization%20is%20incomplete%20for%20the%20full%20cohort.2026-04-29 https://www.reachrx.ai/hub/tag/warning/Wide%2095%25%20uncertainty%20intervals%20(especially%20for%20under-5%20deaths%3A%2053%2C300%E2%80%93149%2C000)%20indicate%20substantial%20uncertainty%20in%20aetiology-specific%20estimates%2C%20particularly%20for%20low-surveillance%20regions.2026-03-31 https://www.reachrx.ai/hub/tag/warning/Wide%20confidence%20intervals%20for%20DAH%20and%20SLS%20estimates%20indicate%20substantial%20uncertainty%20in%20those%20prevalence%20figures.2026-08-07 https://www.reachrx.ai/hub/tag/warning/Wide%20confidence%20intervals%20throughout%20(e.g.%2C%2090-day%20mortality%2095%25%20CI%200.1%E2%80%9319.6%25)%20reflect%20the%20very%20small%20sample%20size%3B%20findings%20should%20be%20considered%20preliminary%20and%20hypothesis-generating%20only.2026-07-30 https://www.reachrx.ai/hub/tag/warning/Wide%20SD%20in%20encounters%20per%20resident%20(up%20to%2049.2)%20suggests%20high%20variability%3B%20the%20impact%20flag%20'limited_evidence'%20reflects%20the%20single-site%2C%20no-comparator%20design%20rather%20than%20the%20quality%20of%20the%20intervention%20itself.2026-05-12 https://www.reachrx.ai/hub/tag/warning/Wide%20standard%20deviations%20in%20follow-up%20duration%20(%C2%B147%E2%80%9348%20months)%20indicate%20variable%20surveillance%20timing%2C%20which%20may%20affect%20patency%20and%20survival%20estimates.2026-07-20 https://www.reachrx.ai/hub/tag/warning/With%20only%2025%20patients%20across%202%20sites%2C%20findings%20are%20hypothesis-generating%20only%3B%20the%20AUROC%20of%200.89%20should%20be%20interpreted%20cautiously%20given%20the%20small%20sample%20size%20and%20absence%20of%20external%20validation.2026-08-05 https://www.reachrx.ai/hub/tag/warning/With%20only%2028%20positive%20cases%2C%20the%20logistic%20regression%20estimates%20(especially%20the%20wide%20CI%20for%20contact%20with%20respiratory-infected%20person%3A%20OR%208.09%2C%2095%25%20CI%201.96%E2%80%9326.02)%20should%20be%20interpreted%20cautiously%20due%20to%20low%20statistical%20power.2026-05-22 https://www.reachrx.ai/hub/tag/warning/With%20only%208%20cases%2C%20this%20study%20is%20hypothesis-generating%20and%20cannot%20support%20generalizable%20conclusions.2026-06-26 https://www.reachrx.ai/hub/tag/warning/With%20only%2080%20participants%2C%20the%20study%20is%20likely%20underpowered%20to%20detect%20moderate%20but%20clinically%20meaningful%20differences%20between%20techniques.2026-07-08 https://www.reachrx.ai/hub/tag/warning/Without%20access%20to%20the%20body%20text%2C%20it%20is%20not%20possible%20to%20confirm%20the%20specific%20arguments%20made%2C%20sample%20sizes%20discussed%2C%20or%20clinical%20recommendations%20offered.2026-03-28 https://www.reachrx.ai/hub/tag/warning/Without%20access%20to%20the%20full%20text%20of%20the%20corrigendum%2C%20it%20is%20impossible%20to%20determine%20what%20was%20corrected%2C%20which%20sections%20were%20affected%2C%20or%20whether%20the%20correction%20has%20clinical%20significance.2026-05-04 https://www.reachrx.ai/hub/tag/warning/Without%20access%20to%20the%20full%20text%2C%20it%20is%20impossible%20to%20confirm%20study%20design%2C%20sample%20size%2C%20clinical%20relevance%2C%20or%20any%20other%20extractable%20fields.2026-06-24 https://www.reachrx.ai/hub/tag/warning/Without%20access%20to%20the%20full%20text%2C%20it%20is%20impossible%20to%20determine%20whether%20this%20piece%20contains%20any%20clinically%20actionable%20information%20or%20study%20data.2026-06-24 https://www.reachrx.ai/hub/tag/warning/Without%20access%20to%20the%20full%20text%2C%20population%2C%20interventions%2C%20and%20quantitative%20details%20could%20not%20be%20extracted.2026-01-05 https://www.reachrx.ai/hub/tag/warning/Without%20detailed%20data%2C%20no%20practice%20implications%20can%20be%20drawn%20from%20this%20source%20alone.2025-07-28 https://www.reachrx.ai/hub/tag/warning/Without%20full%20text%2C%20specific%20formulations%20tested%20and%20quantitative%20benzene%20levels%20are%20unknown.2025-02-12 https://www.reachrx.ai/hub/tag/warning/Without%20numeric%20results%2C%20the%20magnitude%20of%20benefit%20and%20safety%20profile%20cannot%20be%20assessed.2025-11-22 https://www.reachrx.ai/hub/tag/warning/Without%20outcomes%2C%20clinical%20implications%20cannot%20be%20summarized.2025-12-29 https://www.reachrx.ai/hub/tag/warning/Without%20reported%20outcomes%2C%20no%20practice%20takeaway%20can%20be%20given.2026-01-14 https://www.reachrx.ai/hub/tag/warning/Without%20the%20article%20text%2C%20specific%20findings%2C%20numbers%2C%20and%20recommendations%20cannot%20be%20summarized.2025-12-01 https://www.reachrx.ai/hub/tag/warning/Without%20the%20body%20text%20of%20the%20corrigendum%2C%20it%20is%20not%20possible%20to%20determine%20what%20was%20corrected%2C%20its%20clinical%20significance%2C%20or%20whether%20it%20affects%20any%20recommendations.2026-05-04 https://www.reachrx.ai/hub/tag/warning/Without%20the%20full%20text%20of%20the%20corrigendum%2C%20the%20nature%20and%20scope%20of%20the%20corrections%20cannot%20be%20determined.2026-05-04 https://www.reachrx.ai/hub/tag/warning/Women%20represented%20a%20small%20fraction%20of%20ALS%20cases%20(484%20of%2014%2C419%20total)%2C%20so%20female-specific%20hazard%20ratios%20carry%20wider%20confidence%20intervals%20and%20should%20be%20interpreted%20cautiously.2026-07-29 https://www.reachrx.ai/hub/tag/warning/Women%20were%20a%20small%20minority%20of%20the%20sample%20(10%2C858%20out%20of%20379%2C196)%2C%20and%20only%20278%20were%20isotretinoin%20users%2C%20making%20female-specific%20conclusions%20less%20robust.2026-05-20 https://www.reachrx.ai/hub/tag/warning/Women%20with%20prior%20gynecological%20organ%20removal%20or%20mastectomy%20were%20not%20excluded%2C%20which%20may%20affect%20comparability%20with%20other%20studies.2026-05-14 https://www.reachrx.ai/hub/tag/warning/Women%20without%20diabetes%20who%20did%20not%20receive%20ACS%20were%20excluded%20from%20the%20cohort%2C%20so%20a%20full%20four-arm%20comparison%20was%20not%20performed%20%E2%80%94%20direct%20benefit%20vs.%20no-treatment%20in%20non-diabetic%20women%20cannot%20be%20assessed.2026-07-28 https://www.reachrx.ai/hub/tag/warning/Work%20addiction%20lacks%20formal%20DSM%2FICD%20recognition%2C%20so%20there%20is%20no%20diagnostic%20gold%20standard%20against%20which%20to%20validate%20these%20scores%20%E2%80%94%20a%20key%20caveat%20for%20clinical%20use.2026-05-26 https://www.reachrx.ai/hub/tag/warning/wRVUs%20per%20shift%20hour%20is%20an%20indirect%20proxy%20for%20clinical%20productivity%20and%20may%20not%20capture%20all%20meaningful%20dimensions%20of%20physician%20output%20or%20patient%20throughput.2026-06-11 https://www.reachrx.ai/hub/tag/warning/Xenotransplantation%20discussion%20is%20based%20on%20early%20scientific%20findings%20and%20may%20not%20reflect%20current%20clinical%20practice%20as%20of%20the%20paper's%20publication.2025-08-30 https://www.reachrx.ai/hub/tag/warning/Xi-Care%20is%20a%20prototype%20AI%20tool%20under%20development%20by%20the%20study's%20own%20research%20team%20(CIHR-funded)%3B%20participant%20feedback%20on%20it%20may%20be%20influenced%20by%20researcher%20allegiance%20bias.2026-06-19 https://www.reachrx.ai/hub/tag/warning/XQLD%20is%20a%20multi-component%20herbal%20formula%3B%20the%20active%20ingredients%20responsible%20for%20observed%20effects%20were%20not%20isolated%20or%20identified.2026-08-20 https://www.reachrx.ai/hub/tag/warning/Xylazine%20lacks%20a%20dedicated%20ICD-10%20code%2C%20so%20its%20true%20prevalence%20in%20overdose%20deaths%20is%20likely%20underestimated%20in%20this%20dataset.2026-06-02 https://www.reachrx.ai/hub/tag/warning/YAP1%20is%20described%20as%20a%20protein%2Ftranscriptional%20marker%2C%20not%20a%20pharmacological%20agent%3B%20it%20is%20tagged%20under%20'generic'%20as%20a%20molecular%20target%20for%20clarity%2C%20though%20it%20is%20not%20a%20traditional%20drug.2026-04-23 https://www.reachrx.ai/hub/tag/warning/YM155%20is%20described%20as%20a%20BIRC5%20inhibitor%3B%20its%20clinical%20development%20history%20includes%20prior%20trials%20with%20limited%20efficacy%20%E2%80%94%20context%20for%20translational%20relevance%20is%20unclear%20from%20abstract%20alone.2026-05-09 https://www.reachrx.ai/hub/tag/warning/Z-hypnotics%20are%20grouped%20together%20without%20specifying%20individual%20agents%20(e.g.%2C%20zolpidem%2C%20zopiclone%2C%20zaleplon)%3B%20generic%20tag%20for%20zolpidem%20is%20illustrative%20of%20the%20drug%20class%2C%20not%20confirmed%20as%20the%20sole%20agent%20used.2026-04-24 https://www.reachrx.ai/hub/tag/warning/Zalfermin%20is%20an%20investigational%20FGF21%20analogue%20not%20yet%20approved%3B%20the%20brand%20tag%20'Wegovy'%20is%20assigned%20to%20semaglutide%202.4%20mg%20based%20on%20the%20approved%20dose%2C%20though%20the%20trial%20context%20is%20investigational.2026-07-16 https://www.reachrx.ai/hub/tag/warning/Zero%20cases%20of%20gestational%20hypertension%20in%20the%20vegan%20group%20may%20reflect%20small%20sample%20size%20rather%20than%20a%20true%20protective%20effect.2026-04-30 https://www.reachrx.ai/hub/tag/warning/Zero%20QTP%20events%20occurred%20in%20the%20high-risk%20category%20(only%204%20patients)%2C%20making%20it%20impossible%20to%20assess%20the%20score's%20predictive%20value%20at%20the%20high-risk%20threshold.2026-07-04 https://www.reachrx.ai/hub/tag/warning/ZIP-code-level%20census%20data%20as%20a%20proxy%20for%20neighborhood%20risk%20may%20not%20capture%20granular%20environmental%20exposures%20experienced%20by%20individual%20families.2026-07-13 https://www.reachrx.ai/hub/tag/warning/ZIP%20code%E2%80%93level%20geographic%20results%20were%20mentioned%20but%20not%20presented%20in%20the%20abstract.2025-12-16 https://www.reachrx.ai/hub/tag/warning/Zotepine%20is%20not%20approved%20in%20the%20US%20or%20EU%3B%20clinicians%20in%20these%20regions%20cannot%20act%20on%20zotepine%20findings%20directly.2026-04-30 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/age_group/adolescent2026-01-16 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/age_group/adult2026-08-20 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/age_group/mixed2026-08-17 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/age_group/neonate2026-07-28 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/age_group/older_adult2026-08-13 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/age_group/pediatric2026-06-06 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/brand/Benlysta2026-07-21 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/brand/Gazyva2026-07-21 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/brand/Kerendia2026-06-26 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/brand/Keytruda2026-07-11 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/brand/Lupkynis2026-07-21 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/brand/Nubeqa2026-06-20 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/brand/Opdivo2026-05-20 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/brand/Padcev2026-07-11 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/brand/Pluvicto2026-06-28 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/brand/Rituxan2026-08-11 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/brand/Soliris2026-06-09 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/brand/Ultomiris2026-05-23 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/brand/Xtandi2026-05-22 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/brand/Zytiga2026-08-13 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Acute%20Kidney%20Injury2026-08-13 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/AL%20Amyloidosis2026-05-26 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Albuminuria2026-08-17 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/ANCA-Associated%20Vasculitis2026-08-11 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Antibody-Mediated%20Rejection2026-07-23 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Autosomal%20Dominant%20Polycystic%20Kidney%20Disease2026-06-18 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Benign%20Prostatic%20Hyperplasia2026-05-28 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Biochemical%20Recurrence2026-07-03 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Bladder%20Cancer2026-06-27 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Bladder%20Outlet%20Obstruction2026-05-28 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/C3%20Glomerulonephritis2026-06-09 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/C3%20Glomerulopathy2026-08-11 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Cancer2026-07-13 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Carcinoma%20In%20Situ2026-07-15 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Cardiovascular-Kidney-Metabolic%20Syndrome2026-05-23 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Cardiovascular%20Disease2026-08-17 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Castration-Resistant%20Prostate%20Cancer2026-07-15 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Chronic%20Kidney%20Disease2026-08-20 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Clear%20Cell%20Renal%20Cell%20Carcinoma2026-04-27 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/COVID-192026-07-06 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Dense%20Deposit%20Disease2026-06-15 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Diabetic%20Kidney%20Disease2026-06-15 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/End-Stage%20Kidney%20Disease2026-08-12 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/End-Stage%20Renal%20Disease2026-08-12 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Erectile%20Dysfunction2026-08-07 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Focal%20Segmental%20Glomerulosclerosis2026-08-19 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Glomerular%20Disease2026-06-24 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Glomerulonephritis2026-05-26 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Heart%20Failure2026-08-17 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Hemodialysis2026-08-12 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/High-Risk%20Localized%20Prostate%20Cancer2026-07-09 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Hyperkalemia2026-08-04 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Hypertension2026-07-21 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Hyponatremia2026-07-27 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Hypophosphatemia2026-06-30 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/IgA%20Nephropathy2026-07-07 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Kidney%20Disease2026-07-13 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Kidney%20Failure2026-08-17 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Kidney%20Stones2026-07-30 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Kidney%20Transplant2026-06-15 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Kidney%20Transplant%20Rejection2026-07-23 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Kidney%20Transplantation2026-06-20 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Lower%20Urinary%20Tract%20Symptoms2026-06-18 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Lupus%20Nephritis2026-08-12 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Lymph%20Node%20Metastasis2026-08-12 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Male%20Hypogonadism2026-07-20 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Male%20Infertility2026-07-20 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Malnutrition2026-08-13 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Membranous%20Nephropathy2026-08-12 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Metabolic%20Acidosis2026-06-24 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Metastatic%20Castration-Resistant%20Prostate%20Cancer2026-08-13 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Metastatic%20Hormone-Sensitive%20Prostate%20Cancer2026-07-15 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Metastatic%20Prostate%20Cancer2026-07-03 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Minimal%20Change%20Disease2026-07-23 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Monoclonal%20Gammopathy%20of%20Renal%20Significance2026-08-03 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Multiple%20Myeloma2026-08-17 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Muscle-Invasive%20Bladder%20Cancer2026-08-10 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Nephrolithiasis2026-07-30 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Nephrotic%20Syndrome2026-08-12 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Non-Muscle-Invasive%20Bladder%20Cancer2026-07-14 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Nonmuscle-Invasive%20Bladder%20Cancer2026-07-15 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Obesity2026-07-14 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Obstructive%20Sleep%20Apnea2026-07-06 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Overactive%20Bladder2026-07-17 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Papillary%20Renal%20Cell%20Carcinoma2026-08-10 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Peripheral%20Arterial%20Disease2026-05-25 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Peritoneal%20Dialysis2026-05-07 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Peyronie's%20Disease2026-05-14 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Preeclampsia2026-06-23 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Pregnancy-Associated%20Acute%20Kidney%20Injury2026-07-06 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Prostate%20Cancer2026-08-12 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Proteinuria2026-06-03 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Recurrent%20Urinary%20Tract%20Infection2026-06-10 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Renal%20Cell%20Carcinoma2026-07-24 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Renal%20Fibrosis2026-08-08 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Renal%20Mass2026-07-24 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Resistant%20Hypertension2026-08-17 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Sarcopenia2026-08-03 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Sepsis2026-07-28 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Sexual%20Dysfunction2026-07-20 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Sickle%20Cell%20Disease2026-05-16 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Steroid-Resistant%20Nephrotic%20Syndrome2026-08-12 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Systemic%20Lupus%20Erythematosus2026-08-03 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Thrombotic%20Microangiopathy2026-08-03 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Type%202%20Diabetes2026-08-17 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Type%202%20Diabetes%20Mellitus2026-06-08 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Ureteral%20Stones2025-11-20 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Urethral%20Stricture2026-06-04 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Urgency%20Urinary%20Incontinence2026-04-13 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Urinary%20Incontinence2026-06-04 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Urinary%20Tract%20Infection2026-07-15 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Urolithiasis2026-05-31 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/condition/Urothelial%20Carcinoma2026-08-10 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/generic/abiraterone2026-08-13 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/generic/apalutamide2026-08-05 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/generic/azathioprine2026-05-20 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/generic/BCG2026-07-06 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/generic/BCG%20(Bacillus%20Calmette-Gu%C3%A9rin)2026-07-15 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/generic/belimumab2026-07-21 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/generic/canagliflozin2026-05-26 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/generic/creatinine2026-07-24 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/generic/cyclophosphamide2026-07-23 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/generic/cyclosporine2026-06-09 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/generic/cystatin%20C2026-07-24 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/generic/daratumumab2026-07-23 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/generic/darolutamide2026-06-20 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/generic/docetaxel2026-08-05 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/generic/eculizumab2026-06-09 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/generic/enfortumab%20vedotin2026-07-11 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/generic/enzalutamide2026-08-05 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/generic/finerenone2026-08-17 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/generic/Genomic%20Prostate%20Score2026-08-07 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/generic/icodextrin2026-07-01 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/generic/iohexol2026-07-24 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/generic/ipilimumab2026-05-20 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/generic/iptacopan2026-07-03 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/generic/irbesartan2026-04-22 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/generic/mycophenolate%20mofetil2026-07-23 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/generic/nivolumab2026-05-20 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/generic/obinutuzumab2026-07-21 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/generic/pegcetacoplan2026-07-03 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/generic/pembrolizumab2026-07-11 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/generic/ravulizumab2026-05-23 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/generic/rituximab2026-08-11 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/generic/sparsentan2026-04-22 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/generic/tacrolimus2026-06-09 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/generic/voclosporin2026-07-21 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/impact_flag/confirms_prior2026-08-17 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/impact_flag/limited_evidence2026-08-20 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/impact_flag/practice_changing2026-08-17 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/impact_flag/safety_signal2026-07-17 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/level_of_evidence/12026-07-30 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/level_of_evidence/22026-08-13 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/level_of_evidence/32026-08-10 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/level_of_evidence/42026-08-13 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/level_of_evidence/52026-08-20 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/level_of_evidence/62026-08-19 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/level_of_evidence/72026-08-17 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/5-Alpha%20Reductase%20Inhibitor2026-05-17 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/ACE%20Inhibitor2026-08-12 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/Active%20Surveillance2026-08-10 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/Alkylating%20Agent2026-05-29 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/Alpha%20Blocker2026-05-17 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/Androgen%20Deprivation%20Therapy2026-08-05 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/Androgen%20Receptor%20Inhibitor2026-06-20 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/Androgen%20Receptor%20Pathway%20Inhibitor2026-08-13 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/Angiotensin%20Receptor%20Blocker2026-08-12 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/Anti-CD20%20Monoclonal%20Antibody2026-08-11 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/Antibiotic%20Prophylaxis2026-07-15 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/Antibody-Drug%20Conjugate2026-07-11 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/Antiplatelet%20Therapy2026-07-14 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/Artificial%20Intelligence2026-04-16 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/Biomarker2026-07-24 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/BLyS%20Inhibitor2026-07-21 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/Calcineurin%20Inhibitor2026-07-21 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/Cancer%20Screening2026-05-07 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/CAR-T%20Cell%20Therapy2026-06-30 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/CAR%20T-Cell%20Therapy2026-07-21 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/Chemotherapy2026-07-23 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/Complement%20Inhibitor2026-08-11 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/Continuous%20Kidney%20Replacement%20Therapy2026-06-24 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/Corticosteroid2026-07-21 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/Cytotoxic%20Chemotherapy2026-05-12 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/Dialysis2026-07-06 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/Dietary%20Intervention2026-05-12 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/Erythropoiesis-Stimulating%20Agent2026-06-02 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/Focal%20Therapy2026-06-16 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/Genomic%20Classifier2026-08-07 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/GLP-1%20Receptor%20Agonist2026-08-20 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/Glucocorticoid2026-07-23 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/Hemodialysis2026-08-12 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/High-Intensity%20Focused%20Ultrasound2026-07-11 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/Hormonal%20Therapy2026-07-15 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/Immune%20Checkpoint%20Inhibitor2026-07-15 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/Immunosuppressive%20Therapy2026-08-12 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/Implantable%20Tibial%20Neuromodulation2026-04-13 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/Intravenous%20Fluid%20Therapy2026-07-13 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/Intravesical%20Immunotherapy2026-07-15 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/Kidney%20Replacement%20Therapy2026-02-27 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/Kidney%20Transplantation2026-05-25 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/Magnetic%20Resonance%20Imaging2026-06-16 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/Mineralocorticoid%20Receptor%20Antagonist2026-06-26 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/mTOR%20Inhibitor2026-05-28 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/Multiparametric%20MRI2026-08-08 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/Neoadjuvant%20Chemotherapy2026-08-10 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/Non-Steroidal%20Mineralocorticoid%20Receptor%20Antagonist2026-08-20 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/Nonsteroidal%20Mineralocorticoid%20Receptor%20Antagonist2026-05-29 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/Organ%20Transplantation2026-06-20 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/PARP%20Inhibitor2026-08-13 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/Patient-Reported%20Outcome%20Measure2026-07-17 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/PD-1%20Inhibitor2026-06-26 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/Peritoneal%20Dialysis2026-07-01 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/Plant-Based%20Diet2026-05-07 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/Platinum-Based%20Chemotherapy2026-06-27 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/Prostate%20Biopsy2026-06-04 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/PSMA%20PET%20Imaging2026-08-12 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/Radiation%20Therapy2026-07-28 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/Radical%20Cystectomy2026-06-27 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/Radical%20Prostatectomy2026-08-07 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/Radioligand%20Therapy2026-07-03 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/Radiotherapy2026-07-23 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/Reconstructive%20Surgery2026-07-15 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/Red%20Blood%20Cell%20Transfusion2026-06-01 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/Robotic%20Surgery2026-05-26 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/SGLT-2%20Inhibitor2026-04-27 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/SGLT2%20Inhibitor2026-08-20 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/Single-Cell%20RNA%20Sequencing2026-07-28 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/Solid%20Organ%20Transplantation2026-07-27 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/Spatial%20Transcriptomics2026-07-28 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/Stereotactic%20Body%20Radiotherapy2026-07-20 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/Systemic%20Therapy2026-05-12 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/Taxane%20Chemotherapy2026-05-29 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/Testosterone%20Replacement%20Therapy2026-08-11 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/Thiazide%20Diuretic2026-08-04 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/modality/Urinary%20Biomarker2026-08-05 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/sample_size/n%3D12026-07-27 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/sample_size/n%3D1002026-07-06 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/sample_size/n%3D1432026-05-21 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/sample_size/n%3D1782026-08-10 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/sample_size/n%3D22026-07-19 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/sample_size/n%3D282026-05-27 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/sample_size/n%3D3062026-06-16 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/sample_size/n%3D502026-06-08 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/sample_size/n%3D512026-07-02 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/sample_size/n%3D522026-01-14 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/sample_size/n%3D62026-01-21 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/sample_size/n%3D622026-08-12 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/sex/female2026-07-17 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/sex/male2026-08-13 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/sex/mixed2026-08-17 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/study_design/Case%20Report2026-07-27 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/study_design/Case%20Series2026-07-19 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/study_design/Clinical%20Practice%20Guideline2026-07-30 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/study_design/Clinical%20Practice%20Guideline%20Commentary2026-07-21 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/study_design/Cohort%20Study2026-06-20 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/study_design/Commentary2026-06-19 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/study_design/Cross-Sectional2026-01-14 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/study_design/Cross-Sectional%20Study2026-07-22 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/study_design/Editorial2026-07-23 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/study_design/Guideline2026-01-05 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/study_design/Multicenter%20Diagnostic%20Accuracy%20Study2026-08-08 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/study_design/Narrative%20Review2026-08-17 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/study_design/Observational%20Cohort%20Study2026-06-24 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/study_design/Observational%20Study2026-08-05 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/study_design/Prospective%20Cohort%20Study2026-08-13 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/study_design/Prospective%20Observational%20Study2026-06-13 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/study_design/Prospective%20Registry%20Study2026-07-11 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/study_design/Randomized%20Controlled%20Trial2026-08-13 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/study_design/Retrospective%20Cohort2026-01-10 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/study_design/Retrospective%20Cohort%20Study2026-08-10 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/study_design/Retrospective%20Matched%20Cohort%20Study2026-05-20 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/study_design/Retrospective%20Multicenter%20Cohort%20Study2026-06-25 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/study_design/Scoping%20Review2026-05-07 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/study_design/Systematic%20Review%20and%20Meta-analysis2026-06-04 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/study_design/Systematic%20Review%20and%20Meta-Analysis2026-08-12 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/warning/Level%20of%20evidence%20assigned%20as%207%20(expert%20opinion%2Fguideline%20commentary)%20given%20the%20nature%20of%20the%20publication.2026-05-07 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/warning/No%20sample%20size%20is%20applicable%20%E2%80%94%20this%20is%20a%20narrative%20review%2C%20not%20a%20primary%20study.2026-05-23 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/warning/Sex%20distribution%20of%20the%20study%20population%20is%20not%20reported%20in%20the%20abstract.2026-08-12 https://www.reachrx.ai/hub/Urology%20%26%20Nephrology/warning/Sex%20of%20study%20population%20is%20not%20reported%20in%20the%20abstract%3B%20sex%20tag%20omitted.2026-06-30